ATN International, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ATN International, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	457	481	451	439	455	603	726	762	729	728
Selling, general and administrative				139	139	182	224	243	229	220
Selling and marketing	30.3	35.2	35.2	38.7	37.6
General and administrative	90.4	102	104	101	101
Operating expenses	406	426	390	425	446	618	718	749	730	700
Operating income	51.3	55.3	61	13.4	9.18	-15	7.94	13.2	-0.8	28.4
Interest expense	5.36	8.84	7.97	5.01	5.35	9.61	20.4	42.7	49.5	47.8
Other non-operating income	-5.9	-7.76	-7.28	-7.31	-9.09	-7.66	-16	-40.7	-50.2	-56.2
Pre-tax income	45.4	47.6	53.7	6.07	0.09	-22.7	-8.06	-27.5	-51	-27.8
Income tax	21.2	-1.34	18.9	4.11	0.8	-1.88	-0.47	-8.79	-19.1	-4.23
Net income to minority interests	12.1	17.4	15.1	12.8	13.4	1.3	-1.94	-4.22	-5.42	-8.62
Net income	12.1	31.5	19.8	-10.8	-14.1	-22.1	-5.65	-14.5	-26.4	-14.9
EBITDA	127	142	147	103	97.5	87.7	143	155	138	161
EPS, basic	0.75	1.95	1.24	-0.68	-0.89	-1.52	-0.67	-1.25	-2.10	-1.38
EPS, diluted	0.75	1.94	1.24	-0.68	-0.89	-1.52	-0.67	-1.25	-2.10	-1.38
Shares, basic (weighted)	16.1	16.1	16	16	15.9	15.9	15.8	15.6	15.2	15.2
Shares, diluted (weighted)	16.2	16.2	16	16	15.9	15.9	15.8	15.6	15.2	15.2
Dividend per share	1.32	1.02	0.68	0.68	0.68	0.68	0.72	0.87	0.96	1.07

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	270	208	192	161	104	79.6	54.7	49.2	73.4	102
Short-term investments	9.24	7.08	0.39	0.42		0.3	0.3	0.3	0.3	0.4
Receivables	45.4	43.5	38.3	35.9	44.2	73.7	86.8	88	83.7	80.7
Other current assets	28.1	68.1	37.9	24.8	49.5	63.6	59.1	53.8	62.2	50.2
Total current assets	367	343	276	229	240	233	230	281	309	328
Property, plant and equipment	648	643	627	606	536	943	1,056	1,081	1,040	992
Lease right-of-use assets				68.8	63.2	119	109	99.3	99.4	98.2
Goodwill	62.9	64	64	60.7	60.7	40.1	40.1	40.1	4.84	4.84
Intangible assets					7	44.3	32	19.6	12	7.45
Other non-current assets	38.8	36.8	37.7	65.8	52.6	76.1	81	104	107	103
Total assets	1,198	1,206	1,107	1,131	1,084	1,609	1,708	1,784	1,727	1,673
Accounts payable	92.7	116	80.9	74.1	96.2	151	155	182	178	173
Deferred revenue		25.2	13.8	15	18.5	25.3	27.3	31	28.9	27.8
Short-term debt	12.4	10.9	4.69	3.75	3.75	4.67	6.17	24.3	8.23	15.8
Total current liabilities	150	162	141	120	148	221	233	293	267	263
Long-term debt	144	145	86.3	82.7	69.1	327	416	493	549	549
Lease liabilities				56.2	51.1
Other non-current liabilities	47.9	37.1	46.8	57.5	50.6	142	65.9	74.5	65.2	65.1
Total liabilities	389	375	284	325	329	833	939	1,060	1,055	1,032
Total debt	157	156	91	86.4	72.8	367	422	517	557	565
Paid-in capital	160	168	182	188	188	192	198	206	213	220
Retained earnings	538	553	564	542	517	476	450	417	368	312
Treasury stock	-23.1	-36.1	-48.5	-51.1	-59.5	-71.7	-73.8	-90.4	-102	-103
Other comprehensive income	1.73	3.75	-1.61	-3.28	0.28	4.77	6.21	8.27	10.8	14.7
Shareholders' equity	677	689	695	676	646	601	581	541	489	444
Minority interests	132	141	128	130	109	101	96	96.7	106	110
Total equity	809	830	823	806	754	702	677	638	595	554
Total liabilities and equity	1,198	1,206	1,107	1,131	1,084	1,609	1,708	1,784	1,727	1,673
Shares outstanding	16.1	16	16	16	15.9	15.7	15.8	15.4	15.1	15.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	24.2	48.9	34.9	1.97	-0.71	-20.8	-7.58	-18.8	-31.9	-23.5
Depreciation and amortization	76	86.9	85.7	89.1	88.3	103	135	142	138	133
Stock-based compensation	6.41	6.98	6.42	6.38	5.91	6.58	7.41	8.54	8.24	8.54
Deferred income tax	-5.64	-13.5	-23.2	-2.19	-7.32	-6.61	-7.45	-16.8	-12.8	-8.52
Change in receivables	2.6	-4.07	-1.68	-3.51	-17.8	-4.9	-10.4	-19.8
Cash from operations	112	146	116	87.9	86.3	80.5	103	112	128	134
Capital expenditures	-124	-142	-186	-72.7	-75.3	-96.4	-160	-163	-110	-90
Acquisitions	-146	-1.18				-340	-18	1.31
Purchases of investments	-2	-18.1	-3	-25.4	-0.12			-2.12	-0.07	-0.06
Sales and maturities of investments								0.47	0.59	0.87
Cash from investing	-297	-172	-87.3	-88.3	-70.2	-427	-167	-165	-104	-86.8
Debt issued	126	8.57
Stock issued	0.65	1.03	0.07			0.38
Share buybacks	-4.11	-10.6	-1.58	-0.16	-6.59	-10.5	-0.94	-15	-10
Dividends paid	-21	-19.2	-10.9	-10.9	-10.9	-10.8	-10.7	-13.2	-14.7	-15.7
Cash from financing	75.3	-42.1	-55.2	-29.9	-73.4	322	43.4	55.9	2.91	-19.2
Exchange rate effect	-0.63	0.23	-0.3	-0.28	-0.08
Net change in cash	-110	-68.5	-27	-30.5	-57.4	-24.3	-21	2.44	27.1	27.9
Free cash flow	-12.6	3.35	-70.1	15.2	11	-15.9	-57.2	-51.7	17.5	43.9
Interest paid	4.45	7.41	7.24	4.55	4.83	8.23	19.9	39.3	48.1	45.3
Income taxes paid	8.24	13.7	12.5	30.4	6.12	3.97	3.24	2.9	7.3	3.89

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $28.62 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	37.7%	Operating income / revenue.
EBITDA margin	54.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	30.5%	Pre-tax income / revenue.
Net margin	22.5%	Net income / revenue.
FCF margin	5.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.4%	Cash from operations / revenue.
Effective tax rate	19.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	27.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.8%	Net income / average total assets.
Return on invested capital (ROIC)	28.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	29.9%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	11.8%	Capital expenditures / revenue.
D&A / revenue	17.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-0.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	53.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	25.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	17.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	4.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	10.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	4.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	9.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	9.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	150.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	32.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	11.5%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	14.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	9.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-9.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-8.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-7.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-3.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-0.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	9.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.63x	Current assets / current liabilities.
Quick ratio	1.20x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.96x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.86x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	27.3%	Total debt / total assets.
Liabilities / assets	56.6%	Total liabilities / total assets.
Net debt	$195.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.48x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	6.24x	Operating income / interest expense.
Working capital	$209.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	0.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$587.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.39x	Revenue / average total assets.
Fixed asset turnover	0.78x	Revenue / average property, plant and equipment.
Receivables turnover	8.86x	Revenue / average receivables.
Days sales outstanding	41 days	365 x average receivables / revenue.
FCF conversion	25.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	67.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$10.71	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$47.49	Revenue / diluted weighted shares.
FCF per share	$2.68	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.26	Cash from operations / diluted weighted shares.
Book value per share	$38.87	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$38.13	Tangible book value / shares outstanding.
Cash per share	$20.64	(Cash + short-term investments) / shares outstanding.
Payout ratio	10.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	40.7%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$440.8M	Share price x shares outstanding.
Enterprise value	$636.2M	Market cap + total debt - cash - short-term investments.
P/E	2.66x	Market cap / net income. Only when net income is positive.
P/S	0.60x	Market cap / revenue.
P/B	0.74x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.75x	Market cap / tangible book value, when positive.
P/FCF	10.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	3.45x	Market cap / cash from operations, when positive.
EV/Sales	0.87x	Enterprise value / revenue.
EV/EBIT	2.30x	Enterprise value / operating income, when both are positive.
EV/EBITDA	1.58x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.4%	Free cash flow / market cap.
Earnings yield	37.6%	Net income / market cap (the inverse of P/E).
Dividend yield	3.8%	Dividends paid over the period / market cap.
Shareholder yield	3.8%	(Dividends paid + share buybacks) / market cap.

What was ATN International, Inc.'s revenue in fiscal 2025?

ATN International, Inc. reported revenue of $728.0M for fiscal 2025, 0.2% lower than the year before.

Was ATN International, Inc. profitable in fiscal 2025?

No. It reported a net loss of $14.9M.

How much free cash flow did ATN International, Inc. generate in fiscal 2025?

Cash from operations of $133.9M minus capital expenditures of $90.0M left free cash flow of $43.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ATN International, Inc.